David Greenberg

Prof. David Greenberg

The Pediatric Infectious Disease Unit, Ben-Gurion University of the Negev Soroka University Medical Center, Beer-Sheva 84101, Israel

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2006 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
DGDavid Greenberg
David Greenberg
NGNoga Givon-Lavi
Noga Givon-Lavi
ABArnon Broides
Arnon Broides
IBIrena Blancovich
Irena Blancovich
NPNechama Peled
Nechama Peled
RDRon Dagan
Ron Dagan
Background. Exposure to tobacco smoke is associated with higher risk of Streptococcus pneumoniae and Haemophilus influenzae infection. The aim of thi

1 August 2015 in Vaccine
Verified
Journal Article
Closed access
DGDavid Greenberg
David Greenberg
NGNoga Givon-Lavi
Noga Givon-Lavi
SBShalom Ben-Shimol
Shalom Ben-Shimol
JZJacob Bar Ziv
Jacob Bar Ziv
RDRon Dagan
Ron Dagan

1 March 2011 in The Pediatric Infectious Disease Journal
Verified
Journal Article
Closed access
DGDavid Greenberg
David Greenberg
NGNoga Givon-Lavi
Noga Givon-Lavi
NNNitza Newman
Nitza Newman
JBJacob Bar-Ziv
Jacob Bar-Ziv
RDRon Dagan
Ron Dagan
Background: We aimed at estimating pneumococcal serotype-specific disease potential in pediatric community-acquired alveolar pneumonia (CAAP), by comparing nasopharyngeal pneumococcal carriage during disease to carriage in healthy children. Methods: Pneumococcal nasopharyngeal cultures were obtained from children <5 years old admitted to the emergency room or hospitalized with radiologically diagnosed CAAP and from healthy controls. Disease potential was estimated by calculating serotype-specific odds ratios (OR) of a given serotype to be carried during disease compared with healthy children (after adjustment for age, ethnicity, previous antibiotic therapy, and season). Results: A total of 603 and 1504 isolates were obtained from CAAP and healthy children, respectively. A significant OR >1.0 of a specific serotype being carried during disease (suggesting a higher disease potential) was observed with serotypes (by decreasing rank) 1, 5, 22F, 7F, 14, 9V, and 19A. A significant OR <1.0 of being carried during disease (suggesting a lower disease potential) was observed with serotypes 6A, 6B, 23A, and 35B. Carriage of PCV7 serotypes (grouped) during CAAP was highest in age group 6 to 17 months. PCV10 and PCV13 provided significantly higher coverage for both 6 to 17 and 18 to 35 month age groups. Conclusions: It is suggested that serotypes 1, 5, 7F, 9V, 14, 19A, and 22F have a higher disease potential for childhood pneumonia than do serotypes 6A, 6B, 23A, and 35B.

26 August 2011 in European Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
SSShalom Ben Shimol
Shalom Ben Shimol
RDRon Dagan
Ron Dagan
NGNoga Givon-Lavi
Noga Givon-Lavi
ATAsher Tal
Asher Tal
MAMicha Aviram
Micha Aviram
DGDavid Greenberg
David Greenberg

1 June 2023 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
GHGuy Hazan
Guy Hazan
ODOr A. Duek
Or A. Duek
HAHillel Alapi
Hillel Alapi
HMHuram Mok
Huram Mok
AGAlex Ganninger
Alex Ganninger
JHJeffrey A. Haspel
Jeffrey A. Haspel
BACKGROUND. Circadian rhythms are evident in basic immune processes, but it is unclear if rhythms exist in clinical endpoints like vaccine protection. Here, we examined associations between COVID-19 vaccination timing and effectiveness. METHODS. We retrospectively analyzed a large Israeli cohort with timestamped COVID-19 vaccinations (n = 1,515,754 patients over 12 years old, 99.2% receiving BNT162b2). Endpoints included COVID-19 breakthrough infection and COVID-19–associated emergency department visits and hospitalizations. Our main comparison was among patients vaccinated during morning (800–1159 hours), afternoon (1200–1559 hours), or evening hours (1600–1959 hours). We employed Cox regression to adjust for differences in age, sex, and comorbidities. RESULTS. Breakthrough infections differed based on vaccination time, with lowest the rates associated with late morning to early afternoon and highest rates associated with evening vaccination. Vaccination timing remained significant after adjustment for patient age, sex, and comorbidities. Results were consistent in patients who received the basic 2-dose series and who received booster doses. The relationship between COVID-19 immunization time and breakthrough infections was sinusoidal, consistent with a biological rhythm that modifies vaccine effectiveness by 8.6%–25%. The benefits of daytime vaccination were concentrated in younger (50 years old). COVID-19–related hospitalizations varied significantly with the timing of the second booster dose, an intervention reserved for older and immunosuppressed patients (HR = 0.64, morning vs. evening; 95% CI, 0.43–0.97; P = 0.038). CONCLUSION. We report a significant association between the time of COVID-19 vaccination and its effectiveness. This has implications for mass vaccination programs. FUNDING. NIH.

1 September 2018 in Journal of Hospital Infection
Verified
Journal Article
Closed access
DDD. Danino
D. Danino
RMR. Melamed
R. Melamed
BSB. Sterer
B. Sterer
NPN. Porat
N. Porat
GHG. Hazan
G. Hazan
ABA. Borer
A. Borer